Fingerprint
Dive into the research topics of 'A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically